Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05643144 · ClinicalTrials.gov registry record · NA

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

A NA study of Diabetes and Dementia, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT05643144 is a NA study of Diabetes and Dementia that is actively recruiting participants, run by Indiana University. The registered enrollment target is 62 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05643144, a NA study of Diabetes and Dementia, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

Aim 1: Characterize shared decision-making and unmet patient-caregiver dyads needs for patients with diabetes and Alzheimer's Disease and related dementias (ADRD) while using a continuous glucose monitoring (CGM) device. Aim 2: Develop an interactive tool to enhance shared decision-making for diabetes management.

Interventions

  • DEVICE Continuous Glucose Monitoring

Study Locations (1)

Indiana

  • Eskenazi Health - Indianapolis

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2023-06-07
Est. Completion 2026-08-17
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05643144

The ClinicalTrials.gov registry entry for NCT05643144 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring is the first listed.

NCT05643144 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05643144 about?

NCT05643144 is a clinical study titled "Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes". Aim 1: Characterize shared decision-making and unmet patient-caregiver dyads needs for patients with diabetes and Alzheimer's Disease and related dementias (ADRD) while using a continuous glucose monitoring (CGM) device. Aim 2: Develop an interactive tool to enhance shared decision-making for diabe...

What is the current status of trial NCT05643144?

This trial is currently recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2023-06-07. Estimated completion is 2026-08-17.

What conditions does trial NCT05643144 study?

This clinical trial studies the following conditions: Diabetes, Dementia, Hypoglycemia, Alzheimer's Disease (Incl Subtypes).

What interventions are being tested in trial NCT05643144?

The interventions under investigation include: Continuous Glucose Monitoring (DEVICE).

Who is sponsoring clinical trial NCT05643144?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05643144 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.